A human ex vivo dengue virus neutralization assay identifies priority antibodies and epitopes for vaccines and therapeutics.
T. Vu, H. Clapham, V. Huynh, L. Vo, D. Le, N. Vu, G. Nguyen, T. Huynh, K. Duong, V. Tran, H. Huynh, T. Huynh, T. Nguyen, N. Nguyen, T. Luong, , C. Simmons
This study develops an ex vivo dengue virus neutralization assay using mosquitoes to identify potent human monoclonal antibodies and their epitopes for vaccine and therapeutic development.
bioRxiv · Jan 10, 2019Immunology